Forensic · HCWB
HCW Biologics
Top signals
Delisting Notice
Delisting notice or listing-deficiency event (Item 3.01) in the last 24 months.
+30
Bear case preview · free
HCW Biologics Inc. faces elevated execution risk following a delisting notice or listing-deficiency event filed within the last 24 months, signaling potential non-compliance with exchange standards around financial reporting, corporate governance, or minimum price thresholds. The company's status as a small-cap biotech makes it particularly vulnerable to operational disruptions, funding constraints, or disclosure lapses that could accelerate further regulatory friction. Monitor the next 30-90 days for any Rule 12b-1 compliance updates, reverse-split announcements, or material weakness disclosures that would indicate whether management is actively remedying the underlying deficiency.
↑ That's free. The $9 report goes deeper: every filing cited by accession number, 36-month chronology, what to watch next.
What we checked
✓ Red flags · 36mo
1 8-K event (bankruptcy, delisting, restatement, auditor, officer)
✓ Cyber · 12mo
0 Item 1.05 disclosures + buried-cyber scan
✓ Dilution · 24mo
0 S-3 + 424B5 filings
✓ Buried events
Item 8.01 sections classified for hidden material disclosures
$9
· one-time · emailed in under a minute
The full bear case on HCWB
Plain-English brief. Every signal cited to the exact SEC filing. 36-month chronology. What changes next.
✓ No-signals refund: if the algorithm finds zero red flags on your ticker, reply "refund" and I send the $9 back same day. No questions.
Not ready to buy? Get a free preview by email instead
We'll email you the top 3 signals on HCWB + a discount code for the full report. No subscription, no spam.
Score another ticker
Not investment advice. Every signal grounded in a specific SEC filing. Companies may respond via info@filingfirehose.com.